Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

The medication segment was the largest in 2022, favored for its cost-effectiveness and common use as a first-line treatment. .Centriacinar Emphysema Growth: The centriacinar segment, primarily linked ...

Verona Pharma’s Ohtuvayre has a solid market entry, but its valuation is high. Read why VRNA stock remains a buy for ...

Our scans show where there is patchy ventilation in patients with lung disease, and show us which parts of the lung improve ...

TRN-157 is under clinical development by Theron Pharmaceuticals and currently in Phase I for Chronic Obstructive Pulmonary Disease (COPD).

Those key challenges impacting the care of respiratory diseases include delays in diagnosis due to the intermittent nature of ...

For the past 10 years, medications and inhalers began to help less and less with Rose Walsh’s breathing problems. Battling ...

Persistent coughing affects millions of Americans each year, ranging from mild irritations to indicators of serious health ...

New Study Shows Promising Results for COPD Treatment Nov. 20 ... The results of the study, which used organoids derived from embryonic lungs, open up new perspectives ... Nov. 27, 2024 ...

The scan method has enabled the team, led by researchers at Newcastle University, UK, to see how air moves in and out of the ...

Treatment options for end-stage COPD are similar to those used in earlier stages of the condition. These may include: medications pulmonary rehabilitation oxygen therapy The use of any of these ...

Discover the top 19 most notable drugs approved by the FDA in 2024, including Dupixent for COPD and FluMist for self-administration. See the full list here.